Clinical Trial Update: Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of alpha-lipoic acid and mirabegron for insulin resistance and obesity, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• Mirabegron (mirabegron)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Insulin Resistance, Obesity | Phase 2 | Status: NOT_YET_RECRUITING